絞り込み

16599

広告

「denosumab」の検索結果

2581件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Long-term persistence in patients with osteoporosis receiving denosumab in routine practice: 36-month non-interventional, observational study.

Osteonecrosis of the jaws produced by sunitinib: a systematic review.

The severe problem of stopping treatment with denosumab.

Denosumab improves clinical manifestations of hypophosphatemic osteomalacia by adefovir-induced Fanconi syndrome: a case report.

Comparison of Risk of Osteoporotic Fracture in Denosumab vs Alendronate Treatment Within 3 Years of Initiation.

Giant Cell Lesions of the Maxillofacial Skeleton Express RANKL by RNA In Situ Hybridization Regardless of Histologic Pattern.

Evaluation of appropriate use of bisphosphonates and denosumab in patients with cancer.

[How to manage the rebound effect at denosumab discontinuation and avoid multiple vertebral fractures?]

[Bone effects of bisphosphonates and denosumab treatments in breast or prostate cancer].

Effects of denosumab on hypercalcemia and bone mineral density loss in kidney transplant recipients
.

The RANKL-RANK Axis: A Bone to Thymus Round Trip.

Denosumab Therapy in the Management of Aneurysmal Bone Cysts: A Comprehensive Literature Review.

Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: a multicenter retrospective study.

A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in four European countries: Austria, Belgium, Greece, and Italy.

Drug efficacies on bone mineral density and fracture rate for the treatment of postmenopausal osteoporosis: a network meta-analysis.

Resolution of a case of denosumab-related osteonecrosis of the jaw after tooth extraction.

The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment.

Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss.

Complications Encountered with Non-adherence to Regular Follow-up in the Long-term Medical Management of Hyperparathyroidism.

Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります